Comparison of the clinical characteristics and comprehensive assessments of the 2011 and 2017 GOLD classifications for patients with COPD in China

References

• Global Initiative for Chronic Obstructive Lung DiseaseGlobal Strategy for the Diagnosis, Management and Prevention of COPD2017 Available from: http://goldcopd.orgAccessed November 10, 2016
   Google Scholar
• HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypes: the future of COPDAm J Respir Crit Care Med2010182559860420522794
   PubMed Web of Science ®Google Scholar
• AndersonDMacneeWTargeted treatment in COPD: a multi-system approach for a multi-system diseaseInt J Chron Obstruct Pulmon Dis2009432133519750192
   PubMedGoogle Scholar
• FranssenFMHanMKThe ABC of GOLD A-B-C-DEur Respir J20134251166116824178929
   PubMed Web of Science ®Google Scholar
• SorianoJBLamprechtBRamírezASMortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient dataLancet Respir Med20153644345025995071
   PubMed Web of Science ®Google Scholar
• GoossensLMLeimerIMetzdorfNBeckerKRutten-van MölkenMPRutten-vanMMDoes the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trialBMC Pulm Med2014141416325326750
   PubMed Web of Science ®Google Scholar
• KimJYoonHIOhYMYmOLung function decline rates according to GOLD group in patients with chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2015101819182726379432
   PubMed Web of Science ®Google Scholar
• HanMKMuellerovaHCurran-EverettDGOLD 2011 disease severity classification in COPDGene: a prospective cohort studyLancet Respir Med201311435024321803
   PubMed Web of Science ®Google Scholar
• VogelmeierCFCrinerGJMartinezFJGlobal Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive SummaryAm J Respir Crit Care Med2017195555758228128970
   PubMed Web of Science ®Google Scholar
• TudoricNKoblizekVMiravitllesMGOLD 2017 on the way to a phenotypic approach? Analysis from the Phenotypes of COPD in Central and Eastern Europe (POPE) CohortEur Respir J2017494160251828446560
   PubMed Web of Science ®Google Scholar
• SunLChenYWuRLuMYaoWChanges in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in ChinaInt J Chron Obstruct Pulmon Dis2017123095310229118578
   PubMed Web of Science ®Google Scholar
• HögmanMSulkuJStällbergB2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk groupInt J Chron Obstruct Pulmon Dis2018131316517329379281
   PubMed Web of Science ®Google Scholar
• MarçôaRRodriguesDMDiasMClassification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011COPD2018151212629161163
   PubMedGoogle Scholar
• WangKZengGQLiRCycle ergometer and inspiratory muscle training offer modest benefit compared with cycle ergometer alone: a comprehensive assessment in stable COPD patientsInt J Chron Obstruct Pulmon Dis2017122655266828919733
   PubMed Web of Science ®Google Scholar
• JonesPWHardingGBerryPWiklundIChenWHKline LeidyNKlineLNDevelopment and first validation of the COPD Assessment TestEur Respir J200934364865419720809
   PubMed Web of Science ®Google Scholar
• BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• Standardization of Spirometry, 1994 Update. American Thoracic SocietyAm J Respir Crit Care Med19951523110711367663792
   PubMed Web of Science ®Google Scholar
• American Thoracic Society/European Respiratory SocietyATS/ERS Statement on respiratory muscle testingAm J Respir Crit Care Med2002166451862412186831
   PubMed Web of Science ®Google Scholar
• BruschiCCerveriIZoiaMCReference values of maximal respiratory mouth pressures: a population-based studyAm Rev Respir Dis199214637907931519865
   PubMed Web of Science ®Google Scholar
• JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory QuestionnaireAm Rev Respir Dis19921456132113271595997
   PubMed Web of Science ®Google Scholar
• ATS statement, ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, Statement ATSATS statement: guidelines for the six-minute walk testAm J Respir Crit Care Med2002166111111712091180
   PubMed Web of Science ®Google Scholar
• VestboJPrescottEAlmdalTBody mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart StudyAm J Respir Crit Care Med20061731798316368793
   PubMed Web of Science ®Google Scholar
• IschakiEPapatheodorouGGakiEPapaIKoulourisNLoukidesSBody mass and fat-free mass indices in COPD: relation with variables expressing disease severityChest2007132116416917505043
   PubMed Web of Science ®Google Scholar
• BjellandIDahlAAHaugTTNeckelmannDThe validity of the Hospital Anxiety and Depression Scale. An updated literature reviewJ Psychosom Res2002522697711832252
   PubMed Web of Science ®Google Scholar
• CelliBRCoteCGMarinJMThe body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary diseaseN Engl J Med2004350101005101214999112
   PubMed Web of Science ®Google Scholar
• AgustiAEdwardsLDCelliBCharacteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohortEur Respir J201342363664623766334
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
   PubMed Web of Science ®Google Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
   PubMed Web of Science ®Google Scholar
• JonesPWNadeauGSmallMAdamekLCharacteristics of a COPD population categorised using the GOLD framework by health status and exacerbationsRespir Med2014108112913524041746
   PubMed Web of Science ®Google Scholar
• de TorresJPCasanovaCMarínJMPrognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTEThorax201469979980424969641
   PubMed Web of Science ®Google Scholar
• LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med20121861097598122997207
   PubMed Web of Science ®Google Scholar